Back to News
Market Impact: 0.2
Show Me The Money: Natera Delivers Over 120% Gain In Just About A Year
Source: Nasdaq
Healthcare & BiotechMarket Technicals & FlowsInvestor Sentiment & Positioning
Natera shares reached an all-time high of $366.70 yesterday, signaling strong investor demand and positive momentum for the genetic-testing company. The article provides no new fundamental, earnings, or guidance information, limiting the broader market significance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.38
Ticker Sentiment
NTRA0.78
More News
- Stocks face a key hurdle in next week’s U.S.-China summit. Here’s what’s at stake
- Three words from Kevin Warsh have Wall Street wondering how far the Fed will go with rate hikes
- Warren Buffett stepping down as chairman of Berkshire Hathaway: 'Father Time always wins'
- Japan has record 100,000 people aged over 100: How societies are ageing
- Bank of Japan Hikes Interest Rates in a Split Vote; Yen Drops
- Tokenization is set to change stock trading. These stocks could get a boost